Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Daiichi Sankyo Belgium N.V.-S.A., a prominent subsidiary of the global pharmaceutical company Daiichi Sankyo, is headquartered in Belgium and operates extensively across Europe. Founded in 2005, the company has established itself in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular diseases, and vaccines.
Daiichi Sankyo is renowned for its commitment to research and development, with a portfolio that includes unique therapeutic solutions designed to address unmet medical needs. The company’s advanced drug delivery systems and targeted therapies set it apart in a competitive market. With a strong market position, Daiichi Sankyo Belgium has achieved significant milestones, contributing to the advancement of healthcare in the region and beyond.
+28 vs industry average
Daiichi Sankyo Belgium N.V.-S.A.’s score of 70 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Daiichi Sankyo Belgium N.V.-S.A. yet.
Daiichi Sankyo Belgium N.V.-S.A. currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific emissions figures. The company is a current subsidiary of Daiichi Sankyo Company, Limited, which may influence its climate commitments and initiatives.
As part of its corporate family, Daiichi Sankyo Belgium N.V.-S.A. adheres to the climate strategies and targets set by its parent company. These include initiatives related to the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from Daiichi Sankyo Company, Limited. However, specific reduction targets or achievements for Daiichi Sankyo Belgium N.V.-S.A. have not been disclosed.
In the absence of direct emissions data, it is important to note that the company is likely aligned with industry standards for climate action, focusing on reducing its carbon footprint and enhancing sustainability practices as part of its parent company's broader environmental commitments.
No climate goals have been disclosed for Daiichi Sankyo Belgium N.V.-S.A. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more